JPS4916435B1 - - Google Patents

Info

Publication number
JPS4916435B1
JPS4916435B1 JP3545969A JP3545969A JPS4916435B1 JP S4916435 B1 JPS4916435 B1 JP S4916435B1 JP 3545969 A JP3545969 A JP 3545969A JP 3545969 A JP3545969 A JP 3545969A JP S4916435 B1 JPS4916435 B1 JP S4916435B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3545969A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4916435B1 publication Critical patent/JPS4916435B1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12Triazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP3545969A 1968-05-08 1969-05-08 Pending JPS4916435B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS339968 1968-05-08

Publications (1)

Publication Number Publication Date
JPS4916435B1 true JPS4916435B1 (enExample) 1974-04-22

Family

ID=5373920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3545969A Pending JPS4916435B1 (enExample) 1968-05-08 1969-05-08

Country Status (12)

Country Link
JP (1) JPS4916435B1 (enExample)
AT (1) AT306930B (enExample)
BE (1) BE732268A (enExample)
BR (1) BR6908600D0 (enExample)
CA (1) CA921904A (enExample)
CH (1) CH527207A (enExample)
DE (1) DE1922702A1 (enExample)
ES (1) ES366910A1 (enExample)
FR (1) FR2008048A1 (enExample)
GB (1) GB1227691A (enExample)
IT (1) IT1037009B (enExample)
NL (1) NL6906909A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022535386A (ja) * 2019-06-07 2022-08-08 ルートヴィヒ-マクシミリアン-ウニヴェルズィテート ミュンヘン 炭素環ヌクレオシド類似体

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2012888C3 (de) * 1970-03-14 1981-04-02 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden
US6905669B2 (en) 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
US6943249B2 (en) 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US7038038B2 (en) 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US6887855B2 (en) 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US20060014949A1 (en) * 2004-07-13 2006-01-19 Supergen Inc. Compositions and formulations of decitabine polymorphs and methods of use thereof
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
PT2695609T (pt) 2008-05-15 2020-03-02 Celgene Corp Formulações orais de análogos da citidina e métodos de utilização dos mesmos
KR101660549B1 (ko) 2008-08-08 2016-09-27 시노팜 타이완 리미티드 5―아자시토신 뉴클레오시드 및 이의 유도체의 제조 방법
MX2013010945A (es) 2011-03-31 2014-03-12 Celgene Internat Sarl Sintesis de 5 - azacitidina.
PL2750768T3 (pl) 2011-08-30 2019-05-31 Astex Pharmaceuticals Inc Formulacje pochodnej decytabiny
HK1254645A1 (zh) 2015-07-02 2019-07-26 Otsuka Pharmaceutical Co., Ltd. 冻乾药物组合物
WO2017090264A1 (ja) 2015-11-27 2017-06-01 大原薬品工業株式会社 5-アザシチジン又は其の2'-デオキシ体の5'位ジベンジル燐酸エステル
JP6162349B1 (ja) 2016-04-21 2017-07-12 大原薬品工業株式会社 5−アザシチジン類の糖部シリルエーテル誘導体
US10227374B2 (en) 2016-04-21 2019-03-12 Ohara Pharmaceutical Co., Ltd. Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety
WO2017183215A1 (ja) 2016-04-21 2017-10-26 大原薬品工業株式会社 5-アザシチジン類の糖部シリルエーテル誘導体
EP3661522A2 (en) 2017-08-03 2020-06-10 Otsuka Pharmaceutical Co., Ltd. Drug compound and purification methods thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022535386A (ja) * 2019-06-07 2022-08-08 ルートヴィヒ-マクシミリアン-ウニヴェルズィテート ミュンヘン 炭素環ヌクレオシド類似体

Also Published As

Publication number Publication date
DE1922702A1 (de) 1969-11-20
BR6908600D0 (pt) 1973-02-22
IT1037009B (it) 1979-11-10
CH527207A (de) 1972-08-31
FR2008048A1 (enExample) 1970-01-16
AT306930B (de) 1973-04-25
NL6906909A (enExample) 1969-11-11
ES366910A1 (es) 1971-03-16
BE732268A (enExample) 1969-10-01
GB1227691A (enExample) 1971-04-07
CA921904A (en) 1973-02-27

Similar Documents

Publication Publication Date Title
AU428130B2 (enExample)
JPS4916435B1 (enExample)
AU6168869A (enExample)
AU6171569A (enExample)
AU429879B2 (enExample)
AU4304568A (enExample)
AU4811568A (enExample)
AU4744468A (enExample)
BE726242A (enExample)
BE723559A (enExample)
BE728462A (enExample)
BE728249A (enExample)
BE727931A (enExample)
BE727768A (enExample)
BE727687A (enExample)
BE727040A (enExample)
BE726860A (enExample)
BE726503A (enExample)
AU4270368A (enExample)
BE726479A (enExample)
BE726277A (enExample)
BE709435A (enExample)
BE725196A (enExample)
AU463027A (enExample)
AU4464266A (enExample)